351 – 360 of 3679
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Early onset ataxia with comorbid myoclonus and epilepsy : A disease spectrum with shared molecular pathways and cortico-thalamo-cerebellar network involvement
(
- Contribution to journal › Article
-
Mark
Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Agreement between Parkinson Disease Home Diary and Observer Assessments before and after Structured Patient Training
(
- Contribution to journal › Article
-
Mark
Changes over 6 years in secondary health conditions and activity limitations in older adults aging with long-term spinal cord injury
(
- Contribution to journal › Article
-
Mark
Pupil dilation during negative prediction errors is related to brain choline concentration and depressive symptoms in adolescents
(
- Contribution to journal › Article
-
Mark
Brain Tumor Imaging and Treatment Effects. Imaging findings and cognitive function in glioblastoma patients.
2023) In Lund University, Faculty of Medicine Doctoral Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
CenTauR : Toward a universal scale and masks for standardizing tau imaging studies
(
- Contribution to journal › Article
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
(
- Contribution to journal › Article
-
Mark
Rates of Progression in Patients with Alzheimer’s Disease Depending on Apolipoprotein E Genotype and Concomitant Medications.
2023) 16th Clinical Trials on Alzheimer's Disease Conference(
- Contribution to conference › Poster